Boston Scientific CEO touts its TAVR future
Boston Scientific has traditionally come in third in the TAVR marketplace behind Medtronic and Edwards Lifesciences but CEO Michael Mahoney talked about how it plans to change that at the Medtech Conference in Minneapolis last week.